The persistence of ethylene-oxide (75218) induced sister chromatid exchanges was studied in a group of cynomolgus-monkeys 6 years after termination of exposure to the alkylating agent. The animals had been exposed to 50 or 100 parts per million (ppm) ethylene-oxide for 7 hours per day, 5 days per week, over a 2 year period extending from 1979 to 1981. The immediate results of the longterm exposure were a tripling of the background frequency of sister chromatid exchanges. Six years post exposure blood was collected from the femoral vein of 36 adult male monkeys, and lymphocyte cultures were again assessed for the frequency of sister chromatid exchanges. Cells showing more than 40 sister chromatid exchanges were defined as high frequency cells. The mean number of sister chromatid exchanges in the 50ppm dose group ranged from 8.52 to 12.76 in 1981 and from 6.87 to 8.71 in 1987. A two percent incidence of high frequency cells was determined in one of seven 50ppm animals in 1981 as compared to an incidence of between 1 and 3 percent for six of seven animals in 1987. The mean number of sister chromatid exchanges in the 100ppm animals ranged from 11.68 to 17.42 in 1981 and from 7.08 to 12.03 in 1987. Four of five 100ppm animals showed exchange frequencies of greater than or equal to 2 percent in 1981 as compared to seven of seven animals in 1987. The authors conclude that inhalation exposure to ethylene-oxide results in the prolonged elevation of sister chromatid exchanges and is associated with enhancement of the fraction of cells with high frequencies of sister chromatid exchanges.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.